FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and may be used for treating an individual suffering from a persistent, sluggish, partially healing, open or chronic wound. That is ensured by administering anti-connexin 43 polynucleotide approximately 0.001 to approximately 1 mg/kg of body weight into the wound of the individual in a pharmaceutically acceptable carrier. Stimulating and improving wound healing, improving wound healing rate in a diabetic patient and an individual suffering from a chronic skin wound is also suggested. Kits and finished products containing Pluronic F-127 and anti-connexin 43 polynucleotide presented by SEQ ID NO: 1 for wound healing.
EFFECT: group of inventions provides wound healing, relieved inflammation within the persistent wound, as well as minimised cicatrisation.
129 cl, 4 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMPROVED METHODS AND COMPOSITIONS FOR WOUND HEALING | 2007 |
|
RU2542471C2 |
| METHOD OF TREATING WOUNDS | 2014 |
|
RU2672377C1 |
| AQUEOUS PHARMACEUTICAL PREPARATION AND METHOD OF TREATING CHRONIC ULCER | 2014 |
|
RU2707254C1 |
| AGENT FOR THE TREATMENT OF DERMATOLOGICAL DISEASES | 2019 |
|
RU2799211C2 |
| COMPOSITIONS COMPRISING COCKTAILS OF ANTIBACTERIAL PHAGES AND USES THEREOF | 2013 |
|
RU2654596C2 |
| TOPICAL GELS CONTAINING ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES | 2013 |
|
RU2657535C2 |
| METHOD OF TREATING DIABETIC FOOT ULCERS, PRESSURE ULCERS, VENOUS LEG ULCERS AND ASSOCIATED COMPLICATIONS | 2013 |
|
RU2664710C2 |
| COMPOSITIONS AND METHODS, APPLIED FOR ACCELERATION OF WOUND HEALING AND TISSUE REGENERATION | 2005 |
|
RU2438696C2 |
| METHOD OF TREATING KELOIDS OR HYPERTROPHIC SCARS USING ANTISENSE COMPOUNDS, DIRECTLY ACTING ON CONNECTIVE TISSUE GROWTH FACTOR (CTGF) | 2012 |
|
RU2608655C2 |
| SOLUBLE MEDIATOR | 2012 |
|
RU2660580C2 |
